Genetesis, a Mason based biotech company, and its CardioFlux technology is on the road to FDA approval with its recent ‘de novo’ request approval – opening the door for other innovative, novel medical devices and technology.
Read more from CincyInno here.News
L3Harris Announces Acquisition of Aerojet Rocketdyne
Mason-based L3Harris parent company announced its second acquisition of 2022 with a focus on increased investment, leadership, and innovation in advanced tech, hypersonics, and more.
Learn more about the acquisition here.TriHealth Announces “Historic” Partnership with the Cleveland Clinic’s Heart, Vascular & Thoracic Institute
This new and exciting partnership announcement further strengthens the advanced R&D, cardiovascular care, and heart science work in the region. Mason is proud to partner with TriHealth.
Read all the details from the Cincinnati Business Courier.Festo Celebrates its 50th Anniversary
Festo recently celebrated 50 years in business and, for the past seven years, has called Mason home for the company’s Hub of America’s. Through collaboration, Festo’s Didactic Training Center, and strong international leadership, Festo continues to inspire growth in Mason, and across the region.
Check out this feature on their anniversary celebration.